Drug intelligence / Profile preview

Q-Actin

Development stage
Preclinical
Lead developer
IminoTech
Modality
Small Molecules
Administration
Oral
01

Overview

Q-Actin is a proprietary natural product extract derived from cucumber (*Cucumis sativus*), developed by Phytoquest. It is standardized for its content of idoBR1, a bioactive iminosugar that acts as a glycosidase inhibitor. This mechanism of action is associated with the modulation of inflammatory pathways, specifically the reduction of pro-inflammatory cytokines such as TNF-alpha. Q-Actin is primarily marketed as a dietary supplement for joint health, with clinical evidence supporting its efficacy in reducing pain and improving physical function in patients with osteoarthritis. Additionally, Phytoquest is investigating the extract's potential applications in muscle recovery, sports performance, and neuroinflammation-related brain health.

Brand names
Q-Actin
Other names
Cucumis sativus extractCucumber extract(2R,3R,4R,5S)-3,4,5-trihydroxypiperidine-2-carboxylic acid
02

Targets

NeuraminidaseIDUA (Alpha-L-iduronidase)GH (Growth hormone)

Beyond the preview

Go deeper on Q-Actin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Q-Actin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call